Prognostic significance of cathepsins B and L in primary human breast cancer.
暂无分享,去创建一个
J. Foekens | J. Klijn | M. Look | J. Kos | S. Henzen‐Logmans | H. Peters | M. M. Meijer-van Gelder | S. Henzen‐Logmans | W. van Putten | J Kos | M Krasovec | N Cimerman | W L van Putten | S C Henzen-Logmans | M P Look | J A Foekens | N. Cimerman | J G Klijn | H A Peters | M E Meijer-van Gelder | M. Krašovec
[1] H. Höfler,et al. Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin L. , 1998, Anticancer research.
[2] N. Harbeck,et al. Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer. , 1997, British Journal of Cancer.
[3] M. Duffy,et al. The urokinase‐type plasminogen activator system in cancer metastasis: A review , 1997, International journal of cancer.
[4] H. Höfler,et al. Clinical Impact of the Plasminogen Activation System in Tumor Invasion and Metastasis: Prognostic Relevance and Target for Therapy , 1997, Thrombosis and Haemostasis.
[5] M. Duffy,et al. Proteases as prognostic markers in cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] J. Kos,et al. Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer. , 1995, Biological chemistry Hoppe-Seyler.
[7] P. Dettmar,et al. Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] V. Turk,et al. Expression of full-length human procathepsin L cDNA in Escherichia coli and refolding of the expression product. , 1995, Biological chemistry Hoppe-Seyler.
[9] J. Lindtner,et al. Prognostic value of total cathepsin B in invasive ductal carcinoma of the breast. , 1995, European Journal of Cancer.
[10] J. Foekens,et al. Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] D. Rifkin,et al. Biology and biochemistry of proteinases in tumor invasion. , 1993, Physiological reviews.
[12] Robert Gray,et al. Flexible Methods for Analyzing Survival Data Using Splines, with Applications to Breast Cancer Prognosis , 1992 .
[13] J. Foekens,et al. Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. , 1992, Cancer research.
[14] C. Osborne,et al. Prognostic factors for breast cancer: have they met their promise? , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Bonnie F. Sloane,et al. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. , 1992, The Biochemical journal.
[16] J. Calvete,et al. Effective activation of the proenzyme form of the urokinase‐type plasminogen activator (pro‐uPA) by the cysteine protease cathepsin L , 1992, FEBS letters.
[17] R. Golouh,et al. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma , 1992, International journal of cancer.
[18] A. Maseri,et al. Age Dependence of Ischaemic Heart Syndromes and the Contribution of Haemostatic Deviations , 1992 .
[19] M. Pagano,et al. High-performance liquid chromatographic method for the simultaneous purification of cathepsins B, H and L from human liver. , 1991, Journal of chromatography.
[20] J. Calvete,et al. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). , 1991, The Journal of biological chemistry.
[21] M. Gottesman,et al. Expression of cathepsin L in human tumors. , 1991, Cancer research.
[22] W. L. McGuire,et al. Breast cancer prognostic factors: evaluation guidelines. , 1991, Journal of the National Cancer Institute.
[23] Kane Se,et al. The role of cathepsin L in malignant transformation. , 1990 .
[24] Bonnie F. Sloane. Cathepsin B and cystatins: evidence for a role in cancer progression. , 1990, Seminars in cancer biology.
[25] T. Maudelonde,et al. CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCER , 1989, The Lancet.
[26] J. Foekens,et al. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. , 1989, Cancer research.
[27] M. Duffy,et al. Urokinase‐plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report , 1988, Cancer.
[28] J. Bartek,et al. Cytochemical and biochemical evidence of cathepsin B in malignant, transformed and normal breast epithelial cells. , 1987, Journal of cell science.
[29] A. Barrett,et al. Elastinolytic activity of human cathepsin L. , 1986, The Biochemical journal.
[30] J. Mort,et al. Interrelationship of active and latent secreted human cathepsin B precursors. , 1986, The Biochemical journal.
[31] S. Pocock,et al. Regression Models and Non‐Proportional Hazards in the Analysis of Breast Cancer Survival , 1984 .
[32] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .